Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
2
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
75.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed350%
terminated117%
recruiting233%

Recent Activity

2 active trials
Showing 5 of 6
terminated

Cardiovascular Complications of Ibrutinib Therapy

NCT05939752
recruiting

The Value of Measuring Retinal Vascular Density by Optical Coherence Tomography-Angiography (OCT-A) in Patients With Microvascular Angina Confirmed by Myocardial Microcirculatory Resistance Index (MRI).

NCT06692751
completednot_applicable

Ophthalmological Abnormalities in Hereditary Ichthyosis (ICHTYO-KERATO)

NCT03464994
recruiting

Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study

NCT07174141
completednot_applicable

Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)

NCT04978740
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05939752

Cardiovascular Complications of Ibrutinib Therapy

Terminated
NCT06692751

The Value of Measuring Retinal Vascular Density by Optical Coherence Tomography-Angiography (OCT-A) in Patients With Microvascular Angina Confirmed by Myocardial Microcirculatory Resistance Index (MRI).

Recruiting
NCT03464994Not Applicable

Ophthalmological Abnormalities in Hereditary Ichthyosis (ICHTYO-KERATO)

Completed
NCT07174141

Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study

Recruiting
NCT04978740Not Applicable

Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)

Completed
NCT03459508

Ocular Findings in Women With Primary Antiphospholipid Syndrome

Completed

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6